These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 16861611)
1. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake. Laferrère B; Hart AB; Bowers CY Obesity (Silver Spring); 2006 Jun; 14(6):1056-63. PubMed ID: 16861611 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. Laferrère B; Abraham C; Russell CD; Bowers CY J Clin Endocrinol Metab; 2005 Feb; 90(2):611-4. PubMed ID: 15699539 [TBL] [Abstract][Full Text] [Related]
3. Ghrelin increases food intake in obese as well as lean subjects. Druce MR; Wren AM; Park AJ; Milton JE; Patterson M; Frost G; Ghatei MA; Small C; Bloom SR Int J Obes (Lond); 2005 Sep; 29(9):1130-6. PubMed ID: 15917842 [TBL] [Abstract][Full Text] [Related]
4. Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children. Mericq V; Cassorla F; Bowers CY; Avila A; Gonen B; Merriam GR J Pediatr Endocrinol Metab; 2003 Sep; 16(7):981-5. PubMed ID: 14513874 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of food intake in obese subjects by peptide YY3-36. Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E486-92. PubMed ID: 15507538 [TBL] [Abstract][Full Text] [Related]
9. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555 [TBL] [Abstract][Full Text] [Related]
10. Ghrelin restores 'lean-type' hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects. Huda MS; Dovey T; Wong SP; English PJ; Halford J; McCulloch P; Cleator J; Martin B; Cashen J; Hayden K; Wilding JP; Pinkney J Int J Obes (Lond); 2009 Mar; 33(3):317-25. PubMed ID: 19188925 [TBL] [Abstract][Full Text] [Related]
11. Effects of a breakfast spread out over time on the food intake at lunch and the hormonal responses in obese men. Allirot X; Seyssel K; Saulais L; Roth H; Charrié A; Drai J; Goudable J; Blond E; Disse E; Laville M Physiol Behav; 2014 Mar; 127():37-44. PubMed ID: 24472321 [TBL] [Abstract][Full Text] [Related]
14. Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats. Beck B; Richy S; Stricker-Krongrad A Life Sci; 2004 Dec; 76(4):473-8. PubMed ID: 15530508 [TBL] [Abstract][Full Text] [Related]
15. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Lawrence CB; Snape AC; Baudoin FM; Luckman SM Endocrinology; 2002 Jan; 143(1):155-62. PubMed ID: 11751604 [TBL] [Abstract][Full Text] [Related]
16. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260 [TBL] [Abstract][Full Text] [Related]
17. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms. Shah N; Evans WS; Bowers CY; Veldhuis JD J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723 [TBL] [Abstract][Full Text] [Related]
18. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504 [TBL] [Abstract][Full Text] [Related]
19. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Cremonini F; Camilleri M; Vazquez Roque M; McKinzie S; Burton D; Baxter K; Zinsmeister AR Gastroenterology; 2006 Nov; 131(5):1431-9. PubMed ID: 17101319 [TBL] [Abstract][Full Text] [Related]
20. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. le Roux CW; Neary NM; Halsey TJ; Small CJ; Martinez-Isla AM; Ghatei MA; Theodorou NA; Bloom SR J Clin Endocrinol Metab; 2005 Aug; 90(8):4521-4. PubMed ID: 15914532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]